SECsense Logo

Roivant Sciences Ltd. 8-K Report: Key Developments Unveiled on February 10, 2025

$ROIV
Form 8-K
Filed on: 2025-02-10
Source
Roivant Sciences Ltd. 8-K Report: Key Developments Unveiled on February 10, 2025

Based on the section of the financial report provided, here are the key pieces of information and insights extracted:

  1. Entity Information:
  • Name: Roivant Sciences Ltd.
  • CIK (Central Index Key): 0001635088
  • IRS Employer Identification Number (EIN): 98-1173944
  • Address: 7th Floor, 50 Broadway, London SW1H 0DB, GB
  1. Filing Details:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: February 10, 2025
  • Period Covered: February 10, 2025 (indicating it may reflect a specific event or occurrence on that date)
  1. Securities Information:
  • Type of Security: Common Shares
  • Par Value: $0.0000000341740141 (very low par value)
  • Ticker Symbol: ROIV
  • Exchange: NASDAQ
  1. Contact Information:
  • Phone Number: 207-400-3347

Insights:

  • The filing is an 8-K, which generally indicates that the company has new material information to disclose. Investors should review the full report for details on the specific events that prompted this filing.
  • The very low par value of the common shares could suggest either a recent issuance structure or an unusual capital structure, which may attract further analysis.
  • Being listed on NASDAQ under the ticker ROIV positions Roivant Sciences within a prominent market, indicating it is an established company likely engaged in substantial business activities.

Overall, this report may have implications for investors monitoring Roivant Sciences for updates regarding corporate actions, financial performance, or strategic changes as of February 10, 2025.